Persistent CD4+ T cell depression following combination alefacept and methotrexate therapy

Int J Dermatol. 2008 Nov;47(11):1204-6. doi: 10.1111/j.1365-4632.2008.03642.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Aged
  • Alefacept
  • CD4 Lymphocyte Count*
  • CD4-Positive T-Lymphocytes / drug effects*
  • CD4-Positive T-Lymphocytes / immunology
  • Dermatologic Agents / adverse effects*
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Methotrexate / adverse effects*
  • Psoriasis / drug therapy*
  • Recombinant Fusion Proteins

Substances

  • Dermatologic Agents
  • Immunosuppressive Agents
  • Recombinant Fusion Proteins
  • Alefacept
  • Methotrexate